Is Santen Pharmaceutical Co., Ltd. (SNPHY) a Buy, Sell, or Hold?
OTC : SNPHY
Santen Pharmaceutical Co., Ltd. — Institutional Ownership
$11.775 USD
-$0.45 (-3.64%)
- Volume
- 531
- Average Volume
- 3.15K
- Market Capitalization
- $3.79B
- P/E Ratio
- 16.45
- Dividend Yield
- 2.03%
- Price Target
- Year High
- $13.93
- Year Low
- $9.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.34
- Current Ratio
- $2.60
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|
SNPHY Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1764.87 | 327.62M | $578.21B | $81.23B | $34.9B | $531.89B |
| 2025-03-31 | $1420.03 | 348.6M | $495.03B | $93B | $34.23B | $436.26B |
| 2024-03-31 | $1420.89 | 366.89M | $521.31B | $94.58B | $35.16B | $461.88B |
| 2023-03-31 | $1122.88 | 387.42M | $435.03B | $57.9B | $36.21B | $413.33B |
| 2022-03-31 | $1214.10 | 399.78M | $485.37B | $83.01B | $32.93B | $435.28B |
| 2021-03-31 | $1536.16 | 399.46M | $613.63B | $62.89B | $10.15B | $560.88B |
| 2020-03-31 | $1826.32 | 399.16M | $728.99B | $91.43B | $12.33B | $649.89B |
| 2019-03-31 | $1691.30 | 406.17M | $686.95B | $70.8B | $4.06B | $620.22B |
| 2018-03-31 | $1691.66 | 406.42M | $687.52B | $69.28B | $7.6B | $625.83B |
| 2017-03-31 | $1613.65 | 410.34M | $662.15B | $53.3B | $16.93B | $625.78B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1764.87 | 325.01M | $573.6B | $81.23B | $34.9B | $527.28B |
| 2025-12-31 | $1615.58 | 322.72M | $521.38B | $61.59B | $36.17B | $495.97B |
| 2025-09-30 | $1665.74 | 329.97M | $549.64B | $63.56B | $36.19B | $522.28B |
| 2025-06-30 | $1674.43 | 340.16M | $569.58B | $84.58B | $243.69M | $485.24B |
| 2025-03-31 | $1420.03 | 342.16M | $485.87B | $93B | $34.23B | $427.11B |
| 2024-12-31 | $1592.00 | 344.74M | $548.83B | $77.85B | $200.94M | $471.18B |
| 2024-09-30 | $1818.27 | 351.43M | $639B | $84.44B | $221.14M | $554.78B |
| 2024-06-30 | $1649.08 | 360.44M | $594.4B | $89.74B | $202.8M | $504.85B |
| 2024-03-31 | $1420.89 | 363.21M | $516.08B | $94.58B | $34.61B | $456.11B |
| 2023-12-31 | $1385.56 | 353.62M | $489.97B | $82.03B | $33.62B | $441.56B |
| 2023-09-30 | $1361.82 | 360.45M | $490.87B | $64.73B | $33.9B | $460.05B |
| 2023-06-30 | $1217.72 | 372.78M | $453.94B | $45.51B | $34.69B | $443.12B |